#BEGIN_DRUGCARD DB04330

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C29H19Cl2N3O6S

# Chemical_IUPAC_Name:
(2S,3'S,4'S,5'S)-5'-(3,4-dichlorophenyl)-6-methyl-1,3-dioxo-4'-{[4-(1,2,3-thiadiazol-4-yl)phenyl]carbamoyl}-1,3-dihydrospiro[indene-2,2'-oxolane]-3'-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Bilh 434

# HET_ID:
434

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C29H19Cl2N3O6S/c1-13-2-8-17-18(10-13)26(36)29(25(17)35)23(28(38)39)22(24(40-29)15-5-9-19(30)20(31)11-15)27(37)32-16-6-3-14(4-7-16)21-12-41-34-33-21/h2-12,22-24H,1H3,(H,32,37)(H,38,39)/t22-,23+,24+,29-/m0/s1

# InChI_Key:
InChIKey=KNRVCCXHLSHTFW-SEAFADMZSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4330

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
608.449

# Molecular_Weight_Mono:
607.037161459

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1R6N

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
5.06

# Predicted_LogS:
-5.9

# Predicted_Water_Solubility:
7.42e-04 g/l

# Primary_Accession_No:
DB04330

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936950

# PubChem_Substance_ID:
46505529

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00194

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC1=CC=C2C(=O)[C@]3(O[C@@H]([C@H]([C@@H]3C(O)=O)C(=O)NC3=CC=C(C=C3)C3=CSN=N3)C3=CC=C(Cl)C(Cl)=C3)C(=O)C2=C1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:13 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Nucleus

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M14119

# Drug_Target_1_GenBank_ID_Protein:
496195

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
E2

# Drug_Target_1_Gene_Sequence:
>1104 bp
ATGGAAGCAATAGCCAAGCGTTTAGATGCGTGCCAGGATCAGTTGTTAGAACTTTATGAA
GAAAACAGTATTGATATACACAAACACATTATGCATTGGAAATGCATACGATTGGAAAGT
GTATTACTACACAAAGCAAAACAAATGGGCCTGAGCCACATCGGGTTACAAGTAGTACCA
CCATTAACTGTGTCAGAGACTAAAGGACATAATGCTATTGAAATGCAAATGCATTTAGAA
TCCTTAGCAAAAACTCAGTATGGTGTGGAACCTTGGACATTACAGGACACCAGTTATGAA
ATGTGGCTAACACCACCCAAACGGTGCTTTAAAAAACAGGGAAATACTGTGGAGGTAAAA
TTTGATGGCTGTGAAGACAATGTAATGGAGTATGTGGTATGGACACATATATACCTGCAG
GACAACGACTCATGGGTAAAAGTAACTAGTTCCGTAGATGCCAAGGGCATATATTATACA
TGTGGACAATTTAAAACATATTATGTAAATTTTAATAAAGAGGCACAAAAGTATGGTAGT
ACCAATCATTGGGAAGTATGTTATGGCAGCACAGTTATATGTTCTCCTGCATCTGTATCT
AGCACTGTACGAGAAGTATCCATTGCTGAACCTACTACATACACCCCCGCACAGACCACC
GCCCCTACAGTGTCCGCCTGCACCACGGAAGACGGCGTGTCGGCGCCGCCTAGGAAGCGA
GCACGTGGACCGTCCACTAACAACACCCTGTGTGTGGCCAACATCAGATCCGTGGACAGT
ACAATCAACAACATCGTCACTGACAATTACAACAAGCACCAAAGAAGGAACAACTGTCAC
AGTGCAGCTACGCCTATAGTGCAACTGCAAGGTGATTCCAATTGTTTAAAATGTTTTAGA
TATAGACTGAATGACAAATATAAACATTTGTTTGAATTAGCATCTTCAACGTGGCATTGG
GCCTCACCTGAGGCACCACATAAAAATGCAATTGTAACATTAACATATAGCAGTGAGGAA
CAACGTCAGCAATTTTTAAACAGTGTAAAAATACCACCCACCATTAGGCATAAGGTGGGG
TTTATGTCATTACATTTATTGTAA

# Drug_Target_1_General_Function:
Involved in nucleotide binding

# Drug_Target_1_General_References:
3008427	Dartmann K, Schwarz E, Gissmann L, zur Hausen H: The nucleotide sequence and genome organization of human papilloma virus type 11. Virology. 1986 May;151(1):124-30.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3071

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
41710

# Drug_Target_1_Name:
Regulatory protein E2

# Drug_Target_1_Number_of_Residues:
367

# Drug_Target_1_PDB_ID:
1R6K

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00508	PPV_E2_N
PF00511	PPV_E2_C

# Drug_Target_1_Protein_Sequence:
>Regulatory protein E2
MEAIAKRLDACQDQLLELYEENSIDIHKHIMHWKCIRLESVLLHKAKQMGLSHIGLQVVP
PLTVSETKGHNAIEMQMHLESLAKTQYGVEPWTLQDTSYEMWLTPPKRCFKKQGNTVEVK
FDGCEDNVMEYVVWTHIYLQDNDSWVKVTSSVDAKGIYYTCGQFKTYYVNFNKEAQKYGS
TNHWEVCYGSTVICSPASVSSTVREVSIAEPTTYTPAQTTAPTVSACTTEDGVSAPPRKR
ARGPSTNNTLCVANIRSVDSTINNIVTDNYNKHQRRNNCHSAATPIVQLQGDSNCLKCFR
YRLNDKYKHLFELASSTWHWASPEAPHKNAIVTLTYSSEEQRQQFLNSVKIPPTIRHKVG
FMSLHLL

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
E2 regulates viral transcription and DNA replication. It binds to the E2RE response element (5'-ACCNNNNNNGGT-3') present in multiple copies in the regulatory region. It can either activate or repress transcription depending on E2RE's position with regards to proximal promoter elements. Repression occurs by sterically hindering the assembly of the transcription initiation complex. The E1-E2 complex binds to the origin of DNA replication

# Drug_Target_1_SwissProt_ID:
P04015

# Drug_Target_1_SwissProt_Name:
VE2_HPV11

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
7.89

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04330
